BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guillouzo A, Guguen-guillouzo C. HepaRG Cells as a Model for Hepatotoxicity Studies. Stem Cells in Birth Defects Research and Developmental Toxicology. Hoboken: John Wiley & Sons, Inc; 2018. pp. 309-39. [DOI: 10.1002/9781119283249.ch12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Weaver RJ, Blomme EA, Chadwick AE, Copple IM, Gerets HHJ, Goldring CE, Guillouzo A, Hewitt PG, Ingelman-sundberg M, Jensen KG, Juhila S, Klingmüller U, Labbe G, Liguori MJ, Lovatt CA, Morgan P, Naisbitt DJ, Pieters RHH, Snoeys J, van de Water B, Williams DP, Park BK. Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. Nat Rev Drug Discov 2020;19:131-48. [DOI: 10.1038/s41573-019-0048-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 16.0] [Reference Citation Analysis]
2 Huguet A, Lanceleur R, Quenault H, Le Hégarat L, Fessard V. Identification of key pathways involved in the toxic response of the cyanobacterial toxin cylindrospermopsin in human hepatic HepaRG cells. Toxicol In Vitro 2019;58:69-77. [PMID: 30905859 DOI: 10.1016/j.tiv.2019.03.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Barranger A, Le Hégarat L. Towards better prediction of xenobiotic genotoxicity: CometChip technology coupled with a 3D model of HepaRG human liver cells. Arch Toxicol 2022. [PMID: 35419617 DOI: 10.1007/s00204-022-03292-4] [Reference Citation Analysis]